MDElliottMD/Sandbox/CYP2C9: Difference between revisions
From Pharmacopedia
More actions
MDElliottMD (talk | contribs) Expand CYP2C9 substrate section per Mark 2026-05-19 Option C decision: replace bullet list with 36-row sortable wikitable (substrate / therapeutic class / CYP2C9 contribution tier / clinical notes) covering anticoagulants, antiepileptics, NSAIDs, sulfonylureas, ARBs, statins, cannabinoids, antifungals, others. Add Comprehensive-tables pointer section naming Flockhart Indiana University table, FDA Drug Development table, PharmGKB (cited Whirl-Carrillo 2021 PMID 34216021). Add Zanger and Schwab... |
MDElliottMD (talk | contribs) Expand CYP2C9 substrate section per Mark 2026-05-19 Option C decision: replace bullet list with 36-row sortable wikitable (substrate / therapeutic class / CYP2C9 contribution tier / clinical notes) covering anticoagulants, antiepileptics, NSAIDs, sulfonylureas, ARBs, statins, cannabinoids, antifungals, others. Add Comprehensive-tables pointer section naming Flockhart Indiana University table, FDA Drug Development table, PharmGKB (cited Whirl-Carrillo 2021 PMID 34216021). Add Zanger and Schwab... |
||
| Line 12: | Line 12: | ||
{| class="wikitable sortable mw-collapsible mw-collapsed" style="width:100%;" | {| class="wikitable sortable mw-collapsible mw-collapsed" style="width:100%;" | ||
|+ style="white-space:nowrap; text-align:left;" | CYP2C9 substrate table (click to expand) | |+ style="white-space:nowrap; text-align:left;" | near-complete CYP2C9 substrate table (click to expand) | ||
! Substrate !! Therapeutic class !! CYP2C9 contribution !! Clinical notes | ! Substrate !! Therapeutic class !! CYP2C9 contribution !! Clinical notes | ||
|- | |- | ||